In This Section

getzk [at]
Location - People View

3501 Civic Center Blvd
Philadelphia, PA 19104
United States

Research Topics
Kelly D. Getz, PhD, MPH
Kelly D. Getz
Assistant Professor of Epidemiology

Dr. Getz develops and applies advanced methods to enable epidemiologic research that aims to optimize the treatment and supportive care of children with cancer by balancing the therapeutic benefits and toxicity risks with an emphasis in cardio-oncology.



Subscribe to be notified of changes or updates to this page.


Dr. Getz's research is focused on the treatment and supportive care of children and young adults with cancer, and on understanding and balancing the associated therapeutic benefits and toxicity risks, with an emphasis in cardio-oncology. Her overarching research goal is to develop and apply advanced epidemiologic methods to existing data resources in creative ways to enable observational research studies that will impact practice. She hopes that her research will address treatment and outcome disparities, and improve both clinical outcomes and quality of life for pediatric cancer patients across diagnoses, during treatment, and into survivorship.

Her Alex's Lemonade Stand Foundation Young Investigator Award evaluates risk factors for cardiac dysfunction during AML therapy and assesses novel early indicators of cardiotoxicity to identify patients at the highest risk before they progress to overt irreversible cardiomyopathy.

Her NHLBI K01 leverages the strengths of multiple complementary data resources including the clinical trial data, administrative billing data, echocardiographic studies, and large volume electronic health record data to address important questions across the cardiotoxicity risk continuum.

Education and Training

MPH, Boston University (Epidemiology), 2009

PhD, Boston University (Epidemiology), 2014

Postdoctoral Fellow, Children's Hospital of Philadelphia(Pediatric Cancer Epidemiology), 2014-2016

Titles and Academic Titles

Assistant Professor of Epidemiology

Research Scientist

Professional Memberships

Society for Epidemiologic Research, 2010-

Society for Pediatric and Perinatal Epidemiologic Research, 2009-

American Society of Clinical Oncology, 2014-

Children's Oncology Group , 2014-

Professional Awards

GlaxoSmithKline R&D Award for Pharmacodynamic Modeling and Simulation, 2003

Lilly Champion Award for Expertise in Population Pharmacokinetic Modeling, 2004

Boston University Reproductive, Perinatal, and Pediatric Epidemiology Training Program (T32 HD052458), 2009-2013

NIH, NICHD, and CIHR Joint Summer Institute in Reproductive and Perinatal Epidemiology, 2012

Society of Epidemiologic Research First Prize Methods Abstract, 2014

Heart House Roundtable, Cardio-Oncology: Risk Assessment & Management Strategies, 2019

Publication Highlights

Getz KD, Sung L, Ky B, Gerbing RB, Leger KJ, Leahy AB, Sack L, Woods WG, Alonzo T, Gamis , Aplenc R. Occurrence of treatment-related cardiotoxicity and its impact on outcomes among children treated on the AAML0531 Clinical Trial: a report from the Children's Oncology Group. J Clin Oncol. 2019 Jan; 65(12):12-21. PubMed PMID: 30379624
Getz KD, Miller TP, Seif AE, Li Y, Huang Y-SV, Fisher BT, Aplenc R. Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia. PloS ONE. 2018 Jan; 13(2):e0192529. PubMed PMID: 29420604
Getz KD, Miller TP, Seif AE, Li Y, Huang YS, Alonzo T, Gerbing R, Sung L, Hall M, Bagatell R, Gamis A, Fisher BT, Aplenc R. Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report. Cancer Med. 2016 Jan; 5(9):2412-2416. PubMed PMID: 27474232
Getz KD, Li Y, Alonzo TA, Hall M, Gerbing RB, Sung L, Huang YS, Arnold S, Seif AE, Miller TP, Bagatell R, Fisher BT, Adamson PC, Gamis A, Keren R, Aplenc R. Comparison of in-patient costs for children treated on the AAML0531 clinical trial: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Jan; 62(10):1775-1781. PubMed PMID: 25946708
Getz KD, Miller TP, Seif AE, Li Y, Huang YS, Bagatell R, Fisher BT, Aplenc R. A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia. Cancer Med. 2015 Jan; 4(9):1356-1364. PubMed PMID: 26105201

Active Grants/Contracts

Anthracycline-Induced Cardiac Toxicity in Pediatric Acute Myeloid Leukemia

  • Alex's Lemonade Stand Foundation Young Investigator Award
  • 2018-2020
  • PI: Getz

Early Treatment-Related Cardiotoxicity and Subsequent Outcomes in Pediatric Acute Myeloid Leukemia: an Assessment of Development, Progression, and Mitigation

  • NIH K01-HL143153
  • 2018-2023
  • PI: Getz

Links of Interest